USANA HEALTH SCIENCES, INC. Revenues
USANA HEALTH SCIENCES, INC. (USNA) reported Revenues of $298.51 million for the 3-month period ending 2020-09-26, per its 10-Q filed 2020-11-03.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-11-03
- USANA HEALTH SCIENCES, INC. revenues for the quarter ending 2020-09-26 was $298.51M, a 14.55% increase year-over-year.
- USANA HEALTH SCIENCES, INC. revenues for the quarter ending 2020-06-27 was $258.99M, a 1.16% increase year-over-year.
- USANA HEALTH SCIENCES, INC. revenues for the quarter ending 2020-03-28 was $266.62M, a 2.33% decline year-over-year.
- USANA HEALTH SCIENCES, INC. revenues for the quarter ending 2019-12-28 was $271.30M, a 9.27% decline year-over-year.
- USANA HEALTH SCIENCES, INC. revenues for fiscal 2019 was $1.06B, a 10.79% decline from fiscal 2018.
- USANA HEALTH SCIENCES, INC. revenues for fiscal 2018 was $1.19B, a 13.56% increase from fiscal 2017.
- USANA HEALTH SCIENCES, INC. revenues for fiscal 2017 was $1.05B, a 4.09% increase from fiscal 2016.
- USANA HEALTH SCIENCES, INC. revenues for fiscal 2016 was $1.01B.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2020-09-26 | $298.51M 10-Q · filed 2020-11-03 | $557.50M derived: sum of 2 quarters · filed 2020-11-03 | $824.12M 10-Q · filed 2020-11-03 | $1.10B derived: sum of 4 quarters · filed 2020-11-03 |
| 2020-06-27 | $258.99M 10-Q · filed 2020-08-04 | $525.61M 10-Q · filed 2020-08-04 | $796.91M derived: sum of 3 quarters · filed 2020-08-04 | $1.06B derived: sum of 4 quarters · filed 2020-11-03 |
| 2020-03-28 | $266.62M 10-Q · filed 2020-05-05 | $537.92M derived: sum of 2 quarters · filed 2020-05-05 | $798.51M derived: sum of 3 quarters · filed 2020-11-03 | $1.05B derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-12-28 | $271.30M 10-K · filed 2020-02-25 | $531.90M derived: sum of 2 quarters · filed 2020-11-03 | $787.91M derived: sum of 3 quarters · filed 2020-11-03 | $1.06B 10-K · filed 2020-02-25 |
| 2019-09-28 | $260.60M 10-Q · filed 2020-11-03 | $516.61M derived: sum of 2 quarters · filed 2020-11-03 | $789.60M 10-Q · filed 2020-11-03 | $1.09B derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-29 | $256.02M 10-Q · filed 2020-08-04 | $529.01M 10-Q · filed 2020-08-04 | $828.03M derived: sum of 3 quarters · filed 2020-08-04 | $1.12B derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-30 | $272.99M 10-Q · filed 2020-05-05 | $572.01M derived: sum of 2 quarters · filed 2020-05-05 | $868.78M derived: sum of 3 quarters · filed 2020-05-05 | $1.17B derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-29 | $299.02M 10-K · filed 2020-02-25 | $595.79M derived: sum of 2 quarters · filed 2020-02-25 | $897.25M derived: sum of 3 quarters · filed 2020-02-25 | $1.19B 10-K · filed 2020-02-25 |
| 2018-09-29 | $296.77M 10-K · filed 2020-02-25 | $598.23M derived: sum of 2 quarters · filed 2020-02-25 | $890.23M 10-Q · filed 2019-11-05 | $1.16B derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $301.46M 10-K · filed 2020-02-25 | $593.46M 10-Q · filed 2019-08-06 | $866.57M derived: sum of 3 quarters · filed 2020-02-25 | $1.13B derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $292.00M 10-K · filed 2020-02-25 | $565.11M derived: sum of 2 quarters · filed 2020-02-25 | $826.88M derived: sum of 3 quarters · filed 2020-02-25 | $1.08B derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-30 | $273.11M 10-K · filed 2019-02-26 | $534.88M derived: sum of 2 quarters · filed 2019-02-26 | $791.94M derived: sum of 3 quarters · filed 2019-02-26 | $1.05B 10-K · filed 2020-02-25 |
| 2017-09-30 | $261.76M 10-K · filed 2019-02-26 | $518.83M derived: sum of 2 quarters · filed 2019-02-26 | $774.15M 10-Q · filed 2018-11-07 | |
| 2017-07-01 | $257.06M 10-K · filed 2019-02-26 | $512.39M 10-Q · filed 2018-08-08 | ||
| 2017-04-01 | $255.32M 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $1.01B 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |